June 24, 2022

A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?

In this article Steve Lynn from Regulatory Compliance Associates discuss why the top 10 FDA Form 483 issues have remained mostly the same for the past twenty-three years and how the industry can solve these systemic repeat observations.   Read...